Photronics INC Schedule 13G passive stakes

Several American Century entities and the Stowers Institute for Medical Research have collectively disclosed beneficial ownership of over 5% of Photronics, Inc. common stock.

Vanguard Portfolio Management has reported beneficial ownership of over 3 million shares, representing 5.1% of Photronics Inc.'s common stock.

Dimensional Fund Advisors LP has increased its beneficial ownership of Photronics Inc. common stock to 6.2%, holding over 3.6 million shares.

The Vanguard Group has filed an amended Schedule 13G, reporting 0% beneficial ownership in Photronics Inc. following an internal realignment.

The Vanguard Group has filed an Amendment No. 8 to its Schedule 13G, disclosing a 10.09% beneficial ownership stake in Photronics Inc. common stock.

The Vanguard Group has filed an amended Schedule 13G, reporting a 9.95% beneficial ownership stake in Photronics Inc. as a passive investor.

BlackRock, Inc. has filed an amended Schedule 13G, disclosing a beneficial ownership of 15.0% of Photronics Inc.'s common stock as of March 31, 2025.